Non-invasive early detection of Fetal Growth Restriction (FGR), many cases are never detected under the current standard of care.
Reduces total cost to healthcare providers while improving accuracy and reducing uncertainties.
Our close collaboration with healthcare professionals has allowed us to perfect the device and its use, and we are receiving consistently positive feedback.
The device has been developed through several iterations that have all contributed significantly to the final design.
Safety and usability have been our main concerns every time we have improved the design.
We work closely with universities and leverage the latest development in the field of Artificial Intelligence.
This allows us to derive precise and pertinent health-related information from the signals we gather from the human body.